Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β1 and β3 integrins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 14, 2008, Pages 5531-5536

  Bentz, Gretchen L ^a   Yurochko, Andrew D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiogenesis; Cardiovascular disease; Pathogenesis; Receptor ligand mediated signaling

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANGIOGENESIS; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT;

ANTIGENS, CD29; BINDING SITES; CELL MOVEMENT; CELL PROLIFERATION; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; HUMANS; INTEGRIN BETA3; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VIRUS ATTACHMENT;

HUMAN HERPESVIRUS 5;

EID: 44449109018     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0800037105     Document Type: Article

References (34)

1. Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436-1442.
2. Epstein SE, Zhou YF, Zhu J (1999) Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation 100:e20-e28.
3. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143.
4. Streblow DN, Orloff SL, Nelson JA (2001) Do pathogens accelerate atherosclerosis? J Nutr 131:2798S-2804S.
5. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA (2008) in Current Topics in Microbiology and Immunology: Human Cytomegaloviruses, eds Stinski MF, Shenk T (Springer, Berlin), pp 397-415.
6. Söderberg-Nauclér C (2006) Does cytomegalovirus play a causitive role in the development of various inflammatory diseases and cancer? J Intern Med 259:219-246.
7. Sumpio BE, Riley JT, Dardik A (2002) Cells in focus: EC. Int J Biochem Cell Biol 34:1508-1512.
8. Lip GY, Blann AD (2004) Thrombogenesis, atherogenesis and angiogenesis in vascular disease: A new 'vascular triad'. Ann Med 36:119-125.
9. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS (2001) Atherosclerosis and cancer: Common molecular pathways of disease development and progression. Ann NY Acad Sci 947:271-293.
10. Moulton KS (2001) Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3:225-233.
11. Mocarski ES, Jr, Shenk T, Pass RF (2007) in Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), pp 2701-2772.
12. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, Yurochko AD (2006) Human cytomegalovirus (HCMV) infection of ECs promotes naïve monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol 80:11539-11555.
13. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA (1998) Human cytomegalovirus persistently infects aortic ECs. J Virol 72:5661-5668.
14. 3 is a coreceptor for human cytomegalovirus. Nat Med 11:515-521.
15. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456-461.
16. Feire AL, Koss H, Compton T (2004) Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA 101:15470-15475.
17. Muñoz-Chápuli R, Quesada AR, Angel Medina M (2004) Angiogenesis and signal transduction in ECs. Cell Mol Life Sci 61:2224-2243.
18. Serini G, Valdembri D, Bussolino F (2006) Integrins and angiogenesis: A sticky business. Exp Cell Res 312:651-658.
19. Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7(Suppl 4):2- 8.
20. Tabernero J (2007) The role of VEGF and EGFR inhibition: Implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res 5:203-220.
21. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47:149-161.
22. Jault F, et al. (1995) Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69:6697-6704.
23. Loffek S, Zigrino P, Steiger J, Kurschat P, Smola H, Mauch C (2006) Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism. Eur J Cell Biol 85:1167-1177.
24. Smith MS, Bentz GL, Smith PM, Bivins ER, Yurochko AD (2004) HCMV activates PI (3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI (3)K-dependent manner. J Leukoc Biol 76:65-76.
25. Yurochko AD (2008) in Current Topics in Microbiology and Immunology: Human Cytomegaloviruses, eds Stinski MF, Shenk T (Springer, Berlin), pp 205-220.
26. Johnson RA, Ma XL, Yurochko AD, Huang ES (2001) The role of MKK1/2 kinase activity in human cytomegalovirus infection. J Gen Virol 82:493-497.
27. Isaacson MK, Feire AL, Compton T (2007) Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol 81:6241-6247.
28. Smith MS, Bentz GL, Alexander JS, Yurochko AD (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 78:4444-4453.
29. Boehme KW, Guerrero M, Compton T (2006) Human cytomegalovirus envelope glycoproteins B, H are necessary for TLR2 activation in permissive cells. J Immunol 177:7094-7102.
30. Wang D, Shenk T (2005) Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism J Virol 79:10330-10338.
31. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC (2006) Human cytomegalovirus entry into epithelial and ECs depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80:710-722.
32. Siu LL, et al. (2007) Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol 25:2178-2183.
33. Lin MT, Yen ML, Lin CY, Kuo ML (2003) Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64:1029-1036.
34. Zhang F, et al. (2004) Adenovirus E4 gene promotes selective EC survival and angiogenesis via activation of the vascular endothelial-cadherin/ Akt signaling pathway. J Biol Chem 279:11760-11766.